NULISAseq Neuro 220 Panel - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Vitestro’s Aletta robotic blood-draw system has received U.S. Food and Drug Administration De Novo authorization, opening a new regulatory pathway for autonomous phlebotomy as laboratories weigh whether robotic blood collection can scale economically and operationally. Representative image.

Vitestro wins FDA De Novo authorization for Aletta robotic blood draw system

Baidu’s second-quarter 2026 results highlight the tension in its AI transition, with AI Cloud Infrastructure revenue rising 50% and GPU Cloud revenue surging 283% even as legacy businesses weakened and total revenue declined 4%. Representative image.

Baidu GPU cloud surges 283%, but investors punish unfinished AI transition

A66 wrong-way crash kills seven including two Cleveland Police officers near Middlesbrough

Construction of President Donald Trump’s $400 million White House ballroom can continue temporarily after Chief Justice John Roberts stayed a lower-court injunction, keeping the controversial 90,000-square-foot project moving while the dispute over congressional approval remains unresolved. Representative image.

Trump White House ballroom survives immediate shutdown after Supreme Court stay

Read More

Pharma Industry News

Why CNS drug developers are paying attention to Alamar Biosciences’ latest move

How Alamar Biosciences’ Neuro 220 Panel could reshape CNS biomarker discovery and drug trials. Explore the strategic implications now.

bySoujanya Ravi

March 20, 2026

web analytics